BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

589 related articles for article (PubMed ID: 18666236)

  • 21. The modulation of hepatic adenosine triphosphate and inflammation by eicosapentaenoic acid during severe fibrotic progression in the SHRSP5/Dmcr rat model.
    Jia X; Naito H; Yetti H; Tamada H; Kitamori K; Hayashi Y; Yamagishi N; Wang D; Yanagiba Y; Ito Y; Wang J; Tanaka N; Ikeda K; Yamori Y; Nakajima T
    Life Sci; 2012 Jun; 90(23-24):934-43. PubMed ID: 22569299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Docosahexaenoic acid attenuates hepatic inflammation, oxidative stress, and fibrosis without decreasing hepatosteatosis in a Ldlr(-/-) mouse model of western diet-induced nonalcoholic steatohepatitis.
    Depner CM; Philbrick KA; Jump DB
    J Nutr; 2013 Mar; 143(3):315-23. PubMed ID: 23303872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Farnesoid X receptor deficiency induces nonalcoholic steatohepatitis in low-density lipoprotein receptor-knockout mice fed a high-fat diet.
    Kong B; Luyendyk JP; Tawfik O; Guo GL
    J Pharmacol Exp Ther; 2009 Jan; 328(1):116-22. PubMed ID: 18948497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FGF21 protects against hepatic lipotoxicity and macrophage activation to attenuate fibrogenesis in nonalcoholic steatohepatitis.
    Liu C; Schönke M; Spoorenberg B; Lambooij JM; van der Zande HJP; Zhou E; Tushuizen ME; Andreasson AC; Park A; Oldham S; Uhrbom M; Ahlstedt I; Ikeda Y; Wallenius K; Peng XR; Guigas B; Boon MR; Wang Y; Rensen PCN
    Elife; 2023 Jan; 12():. PubMed ID: 36648330
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel hamster nonalcoholic steatohepatitis model induced by a high-fat and high-cholesterol diet.
    Miyaoka Y; Jin D; Tashiro K; Masubuchi S; Ozeki M; Hirokawa F; Hayashi M; Takai S; Uchiyama K
    Exp Anim; 2018 May; 67(2):239-247. PubMed ID: 29311502
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Deficiency in apolipoprotein E has a protective effect on diet-induced nonalcoholic fatty liver disease in mice.
    Karavia EA; Papachristou DJ; Kotsikogianni I; Giopanou I; Kypreos KE
    FEBS J; 2011 Sep; 278(17):3119-29. PubMed ID: 21740524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Chronic-binge ethanol feeding aggravates systemic dyslipidemia in
    Hoebinger C; Rajcic D; Silva B; Hendrikx T
    Front Endocrinol (Lausanne); 2023; 14():1148827. PubMed ID: 37560305
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CD47 Deficiency in Mice Exacerbates Chronic Fatty Diet-Induced Steatohepatitis Through Its Role in Regulating Hepatic Inflammation and Lipid Metabolism.
    Tao HC; Chen KX; Wang X; Chen B; Zhao WO; Zheng Y; Yang YG
    Front Immunol; 2020; 11():148. PubMed ID: 32158445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early diet-induced non-alcoholic steatohepatitis in APOE2 knock-in mice and its prevention by fibrates.
    Shiri-Sverdlov R; Wouters K; van Gorp PJ; Gijbels MJ; Noel B; Buffat L; Staels B; Maeda N; van Bilsen M; Hofker MH
    J Hepatol; 2006 Apr; 44(4):732-41. PubMed ID: 16466828
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of macrophage scavenger receptor MARCO in nonalcoholic steatohepatitis indicates possible involvement of endotoxin in its pathogenic process.
    Yoshimatsu M; Terasaki Y; Sakashita N; Kiyota E; Sato H; van der Laan LJ; Takeya M
    Int J Exp Pathol; 2004 Dec; 85(6):335-43. PubMed ID: 15566430
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic administration of the direct thrombin inhibitor argatroban reduces hepatic inflammation in mice with established fatty liver disease.
    Kassel KM; Sullivan BP; Cui W; Copple BL; Luyendyk JP
    Am J Pathol; 2012 Oct; 181(4):1287-95. PubMed ID: 22841818
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Consumption of Low Dose Fucoxanthin Does Not Prevent Hepatic and Adipose Inflammation and Fibrosis in Mouse Models of Diet-Induced Obesity.
    Kim MB; Bae M; Lee Y; Kang H; Hu S; Pham TX; Park YK; Lee JY
    Nutrients; 2022 May; 14(11):. PubMed ID: 35684079
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dietary Cholic Acid Exacerbates Liver Fibrosis in NASH Model of Sprague-Dawley Rats Fed a High-Fat and High-Cholesterol Diet.
    Ichimura-Shimizu M; Watanabe S; Kashirajima Y; Nagatomo A; Wada H; Tsuneyama K; Omagari K
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012527
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ron Receptor Signaling Ameliorates Hepatic Fibrosis in a Diet-Induced Nonalcoholic Steatohepatitis Mouse Model.
    Allen J; Zhang J; Quickel MD; Kennett M; Patterson AD; Hankey-Giblin PA
    J Proteome Res; 2018 Sep; 17(9):3268-3280. PubMed ID: 30091925
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is Western Diet-Induced Nonalcoholic Steatohepatitis in Ldlr-/- Mice Reversible?
    Lytle KA; Jump DB
    PLoS One; 2016; 11(1):e0146942. PubMed ID: 26761430
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver-specific loss of Perilipin 2 alleviates diet-induced hepatic steatosis, inflammation, and fibrosis.
    Najt CP; Senthivinayagam S; Aljazi MB; Fader KA; Olenic SD; Brock JR; Lydic TA; Jones AD; Atshaves BP
    Am J Physiol Gastrointest Liver Physiol; 2016 May; 310(9):G726-38. PubMed ID: 26968211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of acyl-coenzyme A:cholesterol acyltransferase 2 (ACAT2) prevents dietary cholesterol-associated steatosis by enhancing hepatic triglyceride mobilization.
    Alger HM; Brown JM; Sawyer JK; Kelley KL; Shah R; Wilson MD; Willingham MC; Rudel LL
    J Biol Chem; 2010 May; 285(19):14267-74. PubMed ID: 20231283
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nrf2 deletion causes "benign" simple steatosis to develop into nonalcoholic steatohepatitis in mice fed a high-fat diet.
    Wang C; Cui Y; Li C; Zhang Y; Xu S; Li X; Li H; Zhang X
    Lipids Health Dis; 2013 Nov; 12():165. PubMed ID: 24188280
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Overactivation of intestinal sterol response element-binding protein 2 promotes diet-induced nonalcoholic steatohepatitis.
    Malhotra P; Aloman C; Ankireddy A; Khadra H; Ooka K; Gill RK; Saksena S; Dudeja PK; Alrefai WA
    Am J Physiol Gastrointest Liver Physiol; 2017 Nov; 313(5):G376-G385. PubMed ID: 28774869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Urotensin II receptor knockout mice on an ApoE knockout background fed a high-fat diet exhibit an enhanced hyperlipidemic and atherosclerotic phenotype.
    Bousette N; D'Orleans-Juste P; Kiss RS; You Z; Genest J; Al-Ramli W; Qureshi ST; Gramolini A; Behm D; Ohlstein EH; Harrison SM; Douglas SA; Giaid A
    Circ Res; 2009 Sep; 105(7):686-95, 19 p following 695. PubMed ID: 19696412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.